InvestorsObserver
×
News Home

Will TherapeuticsMD Inc (TXMD) Beat the Rest of the Stocks in the Healthcare Sector?

Monday, August 03, 2020 03:37 PM | InvestorsObserver Analysts

Mentioned in this article

Will TherapeuticsMD Inc (TXMD) Beat the Rest of the Stocks in the Healthcare Sector?

The 22 rating InvestorsObserver gives to TherapeuticsMD Inc (TXMD) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 78 percent of stocks in the Healthcare sector, TXMD’s 22 overall rating means the stock scores better than 22 of all stocks.

Overall Score - 22
TXMD has an Overall Score of 22. Find out what this means to you and get the rest of the rankings on TXMD!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 22 means the stock is more attractive than 22 percent of stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds.

The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With TherapeuticsMD Inc Stock Today?

TherapeuticsMD Inc (TXMD) stock is trading at $1.86 as of 3:35 PM on Monday, Aug 3, an increase of $0.01, or 0.54% from the previous closing price of $1.85. The stock has traded between $1.77 and $1.90 so far today. Volume today is low. So far 2,593,791 shares have traded compared to average volume of 5,318,717 shares.

To see InvestorsObserver's Sentiment Score for TXMD click here.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App